Daily non-political popular news in brief.

Health care opinion leaders support public reporting of health care quality, prices

Health care providers, insurance companies and drug makers should make information about prices available to the public, according to the latest Commonwealth Fund/Modern Healthcare Health Care Opinion Leaders Survey, which finds widespread support for such measures. In addition to the reporting of provider quality and prices, 86 percent of respondents support public reporting of drug prices charged to major purchasers, and 82 percent support the public reporting of medical loss ratios.

Read more »

Keywords: health, care, opinion, leaders, support, public, reporting, quality, prices, leader, price

« Previous | Next »

Similar news on "Health care opinion leaders support public reporting of health care quality, prices":

1. National quality agenda, payment reform, care integration keys to improving quality, patient safety
   07-30-2007 · EurekAlert!
   As health-care quality and patient safety concerns rise, the latest Commonwealth Fund Health Care Opinion Leaders survey finds leaders united behind several key reform measures: More than half (56 percent) support the creation of a new public-private entity to coordinate quality efforts and form a national quality agenda; 95 percent believe that fundamental payment reform is needed; and three-fourths (73 percent) say that greater organization and integration of provider care is necessary for improved quality and efficiency.
   Similar news · Read more »
   
2. Survey: Physicians support pay for performance but oppose public reporting
   03-06-2007 · EurekAlert!
   Although three out of four primary care doctors support the use of financial rewards as an incentive for better medical care, most of them oppose public reporting of such quality assessments. Physicians surveyed for this study worry that current quality measures are not sufficientlyaccurate and that pay-for-performance and public-reporting programs could cause doctors to shun sick, poor or non-compliant patients.
   Similar news · Read more »
   
3. Advance in understanding of blood pressure gene could lead to new treatments
   02-04-2007 · EurekAlert!
   Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
   Similar news · Read more »
   
4. New Congress should focus on covering the uninsured, reducing health costs, according to new survey
   01-08-2007 · EurekAlert!
   Expanding coverage for the uninsured should be the top health care priority for the new Congress over the next five years, identified as "absolutely essential" or "very important" by 88 percent of respondents to the latest Commonwealth Fund Health Care Opinion Leaders survey. Other top priorities are moderating rising health care costs (81 percent), reforming Medicare to ensure long-term solvency (80 percent), and increasing use of information technology to improve quality and safety of patient care (80 percent).
   Similar news · Read more »
   
5. Lower mortality rates associated with hospitals that rank highest on quality of care indicators
   07-16-2007 · EurekAlert!
   A new study from the Harvard School of Public Health shows that patients who go to hospitals ranked higher according to specific quality measures, have a lower chance of dying than patients treated at lower-ranked hospitals.
   Similar news · Read more »
   
6. IQWiG presents a concept for cost-benefit assessment methods in the German health care system
   01-29-2008 · EurekAlert!
   German legislature has expanded the responsibilities of the Institute for Quality and Efficiency in Health Care with the latest Health Care Reform. So far, the assessment of drugs has been limited to their clinical benefit. In future, the Institute is also to consider the costs of therapies and place these costs in relation to the benefits determined beforehand. IQWiG has recently presented a methods proposal that will be discussed broadly with the public in the coming months.
   Similar news · Read more »
   
7. Health care reform and 2008 elections: New reports examine candidates' plans, public's views
   01-15-2008 · EurekAlert!
   Eighty-one percent of Americans believe that in order to help reach the goal of health insurance for all, employers should either provide health insurance to their workers or contribute to the cost of their coverage, according to survey data released today by The Commonwealth Fund. Nearly nine of 10 (88 percent) Democrats, nearly three-quarters (73 percent) of Republicans, and nearly four of five (79 percent) Independents would support such an employer "play or pay" requirement.
   Similar news · Read more »
   
8. SCHIP has been successful overall, should be expanded says new health care opinion leaders survey
   04-23-2007 · EurekAlert!
   As the debate over reauthorization of the State Children's Health Insurance Program (SCHIP) heats up in Washington, a new survey of leaders in health policy and health care finds that large majorities feel the program has been successful in increasing access to health care for low income children (71 percent) and in reducing the rate of uninsured, low-income children (65 percent).
   Similar news · Read more »
   
9. Caring for the sick now a public health priority for developing countries
   05-09-2007 · EurekAlert!
   The epidemic rates of chronic disease such as diabetes, stroke and heart disease, as well as cancer and HIV/AIDS in many low-middle income countries, means they are experiencing a greater need for palliative care than most western countries. Palliative care is commonly used in developed countries to improve the quality of life of patients with life-threatening illnesses, through strategies aimed mainly at pain relief.
   Similar news · Read more »
   
10. Study shows impact of protests on stock prices
    10-08-2007 · EurekAlert!
    Corporate leaders at Dow Chemical, Cracker Barrel and Kodak Eastman have learned the hard way that public protests can drive down the value of an otherwise healthy stock. A new study led by Sarah Soule, professor of sociology at Cornell, and Brayden King, assistant professor of sociology at Brigham Young University, examines how organized public protest affects "abnormal stock price returns."
    Similar news · Read more »